We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) MESTINON pyridostigmine bromide 60mg tablets (New Zealand)
Section 19A approved medicine
(Approval lapsed) MESTINON pyridostigmine bromide 60mg tablets (New Zealand)
Section 19A approval holder
iNova Pharmaceuticals (Australia) Pty Ltd ABN 13 617 871 539
Phone
1800 630 056
Approved until
Status
Expired
Medicines in short supply/unavailable
MESTINON pyridostigmine bromide 60mg tablet bottle - ARTG 13748
Indication(s)
Useful in the treatment of myasthenia gravis.
Images
